Medication info

Boncure Injection (Ibandronate Sodium Trihydrate)

Prescription medicationInjectionsIntravenous injection
Ingredient · strength
Ibandronate Sodium Monohydrate›3.375mg / 1 prefilled syringe
Manufacturer / importer
Lite Pharmtech Co., Ltd.
Appearance
It is an injectable solution in a colorless and transparent prefilled syringe, with a single-use needle attached.
Packaging
1 vial/3mL/prefilled syringe
Approval status
Active

MFDS item code 201504116 · Notified 2015.06.24 · Insurance code 690300461

Summary

Main use
Treatment of osteoporosis in postmenopausal women
Who receives it
Adults · Children
Adult administration
Administer 3mg by intravenous injection over 15 - 30 seconds once every 3 months. Patients should take calcium and vitamin D supplements. If a dose is missed on the scheduled dosing date, administer the injection as soon as possible, and then continue regular dosing at 3-month intervals from that date. Patients with hepatic impairment No dosage adjustment is required. Patients with renal impairment No dosage adjustment is required for patients with mild or moderate renal impairment with serum creatinine of 200µmol/L(2.3mg/dL) or less, or creatinine clearance of 30ml/min or higher. There is insufficient clinical experience in patients with serum creatinine greater than 200µmol/L(2.3mg/dL) or creatinine clearance less than 30ml/min; therefore, administration of this medicine is not recommended. Older adults No dosage adjustment is required.
Child administration
Efficacy and safety have not been studied in children 18 years of age or younger.

Ingredients

Manufacturer
Lite Pharmtech Co., Ltd.

Efficacy & effects

Treatment of osteoporosis in postmenopausal women

  • Osteoporosis
View approved original text

This medication is used to treat osteoporosis commonly occurring in postmenopausal women. It helps to increase bone density, enhance bone strength, and reduce the risk of fractures. Therefore, it is effective in preventing fractures due to osteoporosis and maintaining bone health.

How it is given

Adult administration

Administer 3mg by intravenous injection over 15 - 30 seconds once every 3 months. Patients should take calcium and vitamin D supplements. If a dose is missed on the scheduled dosing date, administer the injection as soon as possible, and then continue regular dosing at 3-month intervals from that date. Patients with hepatic impairment No dosage adjustment is required. Patients with renal impairment No dosage adjustment is required for patients with mild or moderate renal impairment with serum creatinine of 200µmol/L(2.3mg/dL) or less, or creatinine clearance of 30ml/min or higher. There is insufficient clinical experience in patients with serum creatinine greater than 200µmol/L(2.3mg/dL) or creatinine clearance less than 30ml/min; therefore, administration of this medicine is not recommended. Older adults No dosage adjustment is required.

Child administration

Efficacy and safety have not been studied in children 18 years of age or younger.

Precautions

This medication must be administered intravenously, as administration into arteries or around veins may cause tissue damage. Patients with a known allergy to this medication or its components, as well as those with untreated hypocalcemia, should not use this drug. Potential side effects during use may include gastrointestinal issues, muscle pain, joint pain, fatigue, headaches, and rashes, which are mostly mild to moderate. Some patients have reported transient influenza-like symptoms, vasculitis, hypersensitivity reactions, and severe skin reactions. Osteonecrosis of the jaw can occur rarely, so cancer patients or those with poor oral hygiene should receive dental care beforehand and avoid excessive dental treatment while under therapy. Patients receiving this medication should ensure adequate intake of calcium and vitamin D, and regular check-ups are necessary if they have renal function issues or other diseases. If pain in the thigh or groin occurs, the possibility of atypical fractures should be suspected, and consultation with a physician is recommended. It is safer for pregnant or breastfeeding women not to use this medication, and the safety for children under 18 years old has not been established. Caution is needed as overdose may affect kidney and liver functions, and if overdose is suspected, immediate consultation with healthcare professionals is required. This medication should not be mixed with calcium-containing solutions or other intravenous drugs and must only be administered by intravenous injection. After use, the syringe and needle should not be reused and should be disposed of safely.

Side effects

  • Gastritis
  • diarrhea
  • abdominal pain
  • indigestion
  • nausea
  • constipation
  • musculoskeletal pain
  • joint pain
  • muscle pain
  • influenza-like illness
Show 27 more
  • fatigue
  • headache
  • rash
  • bone pain
  • weakness
  • injection site reactions
  • phlebitis
  • thrombophlebitis
  • hypersensitivity reactions
  • angioedema
  • facial swelling
  • edema
  • urticaria
  • uveitis
  • episcleritis
  • scleral inflammation
  • anaphylactic reaction
  • shock
  • exacerbation of asthma
  • Stevens-Johnson syndrome
  • erythema multiforme
  • bullous dermatitis
  • atypical femoral fracture
  • intertrochanteric femoral fracture
  • external auditory canal osteonecrosis
  • acute renal failure
  • sensory loss

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air from entering and at room temperature between 1 to 30 degrees Celsius. Proper storage can help maintain the drug's effectiveness.

Appearance and packaging

Appearance

It is an injectable solution in a colorless and transparent prefilled syringe, with a single-use needle attached.

Package unit

1 vial/3mL/prefilled syringe

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.